< PrevNext > 61. Astrazeneca Cambridge, U.K. Share 2020 U.S.-Booked Air Volume: $12 million Consolidated Global TMC: BCDU.S.-booked air volume for pharmaceutical and biopharmaceutical company AstraZeneca dropped to $12 million in 2020, from $53 million in 2019, according to a BTN estimate. The company, which produces a version of the Covid-19 vaccine being used in several countries, saw revenue increase by 9 percent year-over-year in 2020, to $26.6 billion. The firm employed a workforce of 76,100 as of the end of 2020, up from 70,600 at the close of 2019. AstraZeneca plans to produce zero emissions from global operations by 2025 and make its entire value chain carbon-negative by 2030.